Business

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori.

articleAmarantus Bioscience Holdings, Inc.January 30, 20203/company/amarantus-bioscience-holdings-inc/news/amarantus-acquires-majority-interest-in-cbd-wellness-company-hempori
Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

About this update from Amarantus Bioscience Holdings, Inc.

[{"type":"text","content":"\n  Strong customer retention at both stores in Dallas, TX with growing online presence Focus  on delivering wellness solutions by engaging customers to participate in clinical studies and provide outcomes data to determine utility of branded CBD products  Order placed for hemp smokes to begin tobacco smoking cessation program New York, NY and Dallas, TX , Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (“Amarantus,” or AMBS), a biotechnology holding company pursuing proprietary therapeutics and diagnostics through its subsidiaries, today announced that it has acquired a controlling interest in Hempori, Inc., a CBD wellness retailer in Dallas, TX with 2 stores and a growing physical and online presence. Concurrent with this announcement, Hempori has placed an initial purchase order for hemp smokes from Emerald Organic Products, Inc. (OTCPK: EMOR), an Amarantus partner. Amarantus intends to evaluate a smoking cessation program, with an initial focus of getting feedback on the hemp smokable products from customers who are actively seeking to reduce, or cease, chronic use of cigarettes and/or e-cigarettes “We are very pleased to have come to an agreement to acquire a controlling interest in Hempori after over a year of due diligence,” said Gerald Commissiong, President & CEO of Amarantus. “We began following Hempori right before they opened their first retail store in December 2018, and have been thoroughly impressed with the attention to detail and care with which Hempori manages its customers. We believe much of the value in the CBD space resides in consumer-facing operations, and that the majority of CBD users have some medical condition for which they are seeking wellness solutions. As such, we believe the concept of health-focused CBD wellness centers fits squarely into the emerging health and wellness landscape.  We intend to work closely with partners to optimize the Hempori experience and expand its footprint regionally and across the United States. Amarantus will work closely with Hempori to put Amarantus’ clinical trial and FDA-related experience to work in order to position Hempori as a brand distribution leader in the CBD wellness solutions space for customers with medical probl...

More updates from Amarantus Bioscience Holdings, Inc.